奥马珠单抗用于预防一名严重蚊虫过敏患者的过敏反应发作。
Omalizumab for prevention of anaphylactic episodes in a patient with severe mosquito allergy.
作者信息
Meucci Elisa, Radice Anna, Fassio Filippo, Iorno Maria Loredana Chiara, Macchia Donatella
机构信息
Allergy and Clinical Immunology Unit San Giovanni di Dio Hospital Florence Italy.
出版信息
Clin Case Rep. 2021 Oct 21;9(10):e04935. doi: 10.1002/ccr3.4935. eCollection 2021 Oct.
Abstract
Anaphylaxis after mosquito bite is rare, but life threatening. No approved preventive therapy is available to date, but omalizumab could be a promising therapeutic option for reducing risk and improving quality of life in these patients.
摘要
蚊虫叮咬后发生过敏反应虽罕见，但可危及生命。目前尚无获批的预防性治疗方法，但奥马珠单抗可能是降低这些患者风险并改善其生活质量的一种有前景的治疗选择。
相似文献
1
Omalizumab for prevention of anaphylactic episodes in a patient with severe mosquito allergy.
Clin Case Rep. 2021 Oct 21;9(10):e04935. doi: 10.1002/ccr3.4935. eCollection 2021 Oct.
2
Real life study of the use of omalizumab for pediatric patients with multiple food allergies.
Allergol Immunopathol (Madr). 2021 Mar 1;49(2):15-22. doi: 10.15586/aei.v49i2.36. eCollection 2021.
3
American Academy of Allergy, Asthma & Immunology/American College of Allergy, Asthma and Immunology Joint Task Force Report on omalizumab-associated anaphylaxis.
J Allergy Clin Immunol. 2007 Dec;120(6):1373-7. doi: 10.1016/j.jaci.2007.09.032. Epub 2007 Nov 9.
4
Treatment with a combination of omalizumab and specific immunotherapy for severe anaphylaxis after a wasp sting.
Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1):109-12. doi: 10.1177/039463201402700114.
5
Anaphylactic risk related to omalizumab, benralizumab, reslizumab, mepolizumab, and dupilumab.
Clin Transl Allergy. 2021 Jun 3;11(4):e12038. doi: 10.1002/clt2.12038. eCollection 2021 Jun.
6
Omalizumab ensures compatibility to bee venom immunotherapy (VIT) after VIT-induced anaphylaxis in a patient with systemic mastocytosis.
Allergol Select. 2021 Mar 11;5:128-132. doi: 10.5414/ALX02196E. eCollection 2021.
7
Use of omalizumab in the treatment of food allergy and anaphylaxis.
Curr Allergy Asthma Rep. 2013 Feb;13(1):78-84. doi: 10.1007/s11882-012-0316-x.
8
Omalizumab-associated anaphylactic reactions reported between January 2007 and June 2008.
Ann Allergy Asthma Immunol. 2009 Nov;103(5):442-5. doi: 10.1016/S1081-1206(10)60366-3.
9
Combining Anti-IgE Monoclonal Antibodies and Oral Immunotherapy for the Treatment of Food Allergy.
Clin Rev Allergy Immunol. 2022 Feb;62(1):216-231. doi: 10.1007/s12016-021-08902-0. Epub 2021 Sep 22.
10
Diagnosis and treatment of Hymenoptera venom allergy: S2k Guideline of the German Society of Allergology and Clinical Immunology (DGAKI) in collaboration with the Arbeitsgemeinschaft für Berufs- und Umweltdermatologie e.V. (ABD), the Medical Association of German Allergologists (AeDA), the German Society of Dermatology (DDG), the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNOKC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Allergy and Environmental Medicine (GPA), German Respiratory Society (DGP), and the Austrian Society for Allergy and Immunology (ÖGAI).
Allergol Select. 2023 Oct 2;7:154-190. doi: 10.5414/ALX02430E. eCollection 2023.
引用本文的文献
1
Allergen Immunotherapy: Pitfalls, Perks and Unexpected Allies.
Int J Mol Sci. 2025 Apr 9;26(8):3535. doi: 10.3390/ijms26083535.
2
An Aedes-Anopheles Vaccine Candidate Supplemented with BCG Epitopes Against the Aedes and Anopheles Genera to Overcome Hypersensitivity to Mosquito Bites.
Acta Parasitol. 2024 Mar;69(1):483-504. doi: 10.1007/s11686-023-00771-1. Epub 2024 Jan 9.
3
Update on mosquito bite reaction: Itch and hypersensitivity, pathophysiology, prevention, and treatment.
Front Immunol. 2022 Sep 21;13:1024559. doi: 10.3389/fimmu.2022.1024559. eCollection 2022.
本文引用的文献
1
Omalizumab ensures compatibility to bee venom immunotherapy (VIT) after VIT-induced anaphylaxis in a patient with systemic mastocytosis.
Allergol Select. 2021 Mar 11;5:128-132. doi: 10.5414/ALX02196E. eCollection 2021.
2
A randomized double-blind, placebo-controlled study of omalizumab for idiopathic anaphylaxis.
J Allergy Clin Immunol. 2021 Mar;147(3):1004-1010.e2. doi: 10.1016/j.jaci.2020.11.005. Epub 2020 Nov 19.
3
Safety and immunogenicity of a mosquito saliva peptide-based vaccine: a randomised, placebo-controlled, double-blind, phase 1 trial.
Lancet. 2020 Jun 27;395(10242):1998-2007. doi: 10.1016/S0140-6736(20)31048-5. Epub 2020 Jun 11.
4
Treatment of idiopathic anaphylaxis with omalizumab.
Ann Allergy Asthma Immunol. 2019 Dec;123(6):612-613. doi: 10.1016/j.anai.2019.09.020. Epub 2019 Sep 27.
5
"It's not an illness, it's just bad luck": The impact of anaphylaxis on quality of life in adults.
Clin Exp Allergy. 2019 Jul;49(7):1040-1046. doi: 10.1111/cea.13410.
6
Idiopathic anaphylaxis.
Clin Exp Allergy. 2019 Jul;49(7):942-952. doi: 10.1111/cea.13402. Epub 2019 May 13.
7
Omalizumab Therapy for Mast Cell-Mediator Symptoms in Patients with ISM, CM, MMAS, and MCAS.
J Allergy Clin Immunol Pract. 2019 Sep-Oct;7(7):2387-2395.e3. doi: 10.1016/j.jaip.2019.03.039. Epub 2019 Apr 5.
8
Aedes communis Reactivity Is Associated with Bee Venom Hypersensitivity: An in vitro and in vivo Study.
Int Arch Allergy Immunol. 2018;176(2):101-105. doi: 10.1159/000488866. Epub 2018 May 22.
9
Chronic Active Epstein-Barr Virus Disease.
Front Immunol. 2017 Dec 22;8:1867. doi: 10.3389/fimmu.2017.01867. eCollection 2017.
10
EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy.
Allergy. 2018 Apr;73(4):744-764. doi: 10.1111/all.13262. Epub 2017 Dec 5.
Zotero 插件